HIMS — Hims & Hers Health Cashflow Statement
0.000.00%
Last trade - 00:00- $6.24bn
- $5.94bn
- $1.48bn
- 91
- 18
- 97
- 77
Annual cashflow statement for Hims & Hers Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -3.05 | -108 | -65.7 | -23.5 | 126 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | -1.74 | 69.1 | 46.5 | 66.7 | 91 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 4.01 | 3.46 | -14.2 | 20.8 | 78.6 |
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -0.777 | -34.4 | -26.5 | 73.5 | 251 |
| Capital Expenditures | — | -5.01 | -7.25 | -26.5 | -52.8 |
| Purchase of Fixed Assets | |||||
| Software Development Costs | |||||
| Other Investing Cash Flow Items | 0.325 | -151 | 41.9 | 14.4 | 33.7 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0.325 | -156 | 34.7 | -12.1 | -19 |
| Financing Cash Flow Items | 0 | -18.8 | -36.6 | -14.1 | -55.7 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0 | 235 | -33.1 | -11.5 | -108 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.452 | 44.3 | -25 | 49.9 | 124 |